STipe Therapeutics (private company)

See something wrong or missing? Let us know
Offices:Aarhus
Business model:B2B

STipe Therapeutics is a biotechnology company with a vision to become a leader in the immune-oncology field, pioneer therapies using a novel aspect of the stimulator of interferon genes (STING) Pathway to target cancer.

Investors: we tracked 3 investors

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

Investments 21.81M


You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to STipe Therapeutics

Name Criteria
Denmark Galecto Biotech
73%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: Sunstone Life Science Ventures
  • At least one other investor: Novo A/S
  • Total raised in a similar range: 10M+ USD
Germany Adrenomed AG
63%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: Wellington Partners
  • Total raised in a similar range: 10M+ USD
Finland Forendo Pharma
63%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: Sunstone Life Science Ventures
  • Total raised in a similar range: 10M+ USD
Denmark MinervaX
63%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: Sunstone Life Science Ventures, Wellington Partners
  • Total raised in a similar range: 10M+ USD
Sweden OxThera
63%
  • Similar verticals: Biotech, Pharma
  • Similar business models: B2B
  • At least one vc investor: Sunstone Life Science Ventures
  • Total raised in a similar range: 10M+ USD
Switzerland Synendos Therapeutics
63%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: Sunstone Life Science Ventures
  • Total raised in a similar range: 10M+ USD
Denmark IO Biotech
60%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • At least one vc investor: Sunstone Life Science Ventures
  • At least one other investor: Novo A/S
  • Total raised in a similar range: 10M+ USD
Denmark Orphazyme
60%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • At least one vc investor: Sunstone Life Science Ventures
  • At least one other investor: Novo A/S
  • Total raised in a similar range: 10M+ USD
Sweden Gesynta Pharma
58%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: Novo A/S
  • Total raised in a similar range: 10M+ USD
Finland Rappta Therapeutics
58%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one other investor: Novo A/S
  • Total raised in a similar range: 10M+ USD
Top